vs
Side-by-side financial comparison of Academy Sports & Outdoors, Inc. (ASO) and Medpace Holdings, Inc. (MEDP). Click either name above to swap in a different company.
Academy Sports & Outdoors, Inc. is the larger business by last-quarter revenue ($1.4B vs $708.5M, roughly 2.0× Medpace Holdings, Inc.). Medpace Holdings, Inc. runs the higher net margin — 19.1% vs 5.2%, a 13.9% gap on every dollar of revenue. On growth, Medpace Holdings, Inc. posted the faster year-over-year revenue change (32.0% vs 3.0%). Medpace Holdings, Inc. produced more free cash flow last quarter ($188.1M vs $-13.6M). Over the past eight quarters, Medpace Holdings, Inc.'s revenue compounded faster (17.7% CAGR vs -12.2%).
Academy Sports + Outdoors is an American sporting-goods store chain with corporate offices in the Katy Distribution Center in unincorporated western Harris County, Texas, United States, near Katy and west of Houston. For 74 years, it was a privately held company owned by the Gochman family, until its May 2011 acquisition by Kohlberg Kravis Roberts. In October 2020, it was listed on NASDAQ.
Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
ASO vs MEDP — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $708.5M |
| Net Profit | $71.6M | $135.1M |
| Gross Margin | 35.7% | — |
| Operating Margin | 7.3% | 21.6% |
| Net Margin | 5.2% | 19.1% |
| Revenue YoY | 3.0% | 32.0% |
| Net Profit YoY | 8.8% | 15.5% |
| EPS (diluted) | $1.05 | $4.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $708.5M | ||
| Q3 25 | $1.6B | $659.9M | ||
| Q2 25 | $1.4B | $603.3M | ||
| Q1 25 | $1.7B | $558.6M | ||
| Q4 24 | $1.3B | $536.6M | ||
| Q3 24 | $1.5B | $533.3M | ||
| Q2 24 | $1.4B | $528.1M | ||
| Q1 24 | $1.8B | $511.0M |
| Q4 25 | $71.6M | $135.1M | ||
| Q3 25 | $125.4M | $111.1M | ||
| Q2 25 | $46.1M | $90.3M | ||
| Q1 25 | $133.6M | $114.6M | ||
| Q4 24 | $65.8M | $117.0M | ||
| Q3 24 | $142.6M | $96.4M | ||
| Q2 24 | $76.5M | $88.4M | ||
| Q1 24 | $168.2M | $102.6M |
| Q4 25 | 35.7% | — | ||
| Q3 25 | 36.0% | — | ||
| Q2 25 | 34.0% | — | ||
| Q1 25 | 32.2% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 36.1% | — | ||
| Q2 24 | 33.4% | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | 7.3% | 21.6% | ||
| Q3 25 | 10.8% | 21.5% | ||
| Q2 25 | 5.1% | 20.9% | ||
| Q1 25 | 9.2% | 20.3% | ||
| Q4 24 | 6.8% | 23.4% | ||
| Q3 24 | 12.3% | 21.1% | ||
| Q2 24 | 7.5% | 19.9% | ||
| Q1 24 | 11.4% | 20.4% |
| Q4 25 | 5.2% | 19.1% | ||
| Q3 25 | 7.8% | 16.8% | ||
| Q2 25 | 3.4% | 15.0% | ||
| Q1 25 | 8.0% | 20.5% | ||
| Q4 24 | 4.9% | 21.8% | ||
| Q3 24 | 9.2% | 18.1% | ||
| Q2 24 | 5.6% | 16.7% | ||
| Q1 24 | 9.4% | 20.1% |
| Q4 25 | $1.05 | $4.65 | ||
| Q3 25 | $1.85 | $3.86 | ||
| Q2 25 | $0.68 | $3.10 | ||
| Q1 25 | $1.85 | $3.67 | ||
| Q4 24 | $0.92 | $3.67 | ||
| Q3 24 | $1.95 | $3.01 | ||
| Q2 24 | $1.01 | $2.75 | ||
| Q1 24 | $2.19 | $3.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $289.5M | $497.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.1B | $459.1M |
| Total Assets | $5.4B | $2.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $289.5M | $497.0M | ||
| Q3 25 | $300.9M | $285.4M | ||
| Q2 25 | $285.1M | $46.3M | ||
| Q1 25 | $288.9M | $441.4M | ||
| Q4 24 | $296.0M | $669.4M | ||
| Q3 24 | $324.6M | $656.9M | ||
| Q2 24 | $378.1M | $510.9M | ||
| Q1 24 | $347.9M | $407.0M |
| Q4 25 | $2.1B | $459.1M | ||
| Q3 25 | $2.1B | $293.6M | ||
| Q2 25 | $1.9B | $172.4M | ||
| Q1 25 | $2.0B | $593.6M | ||
| Q4 24 | $2.0B | $825.5M | ||
| Q3 24 | $2.0B | $881.4M | ||
| Q2 24 | $1.9B | $763.6M | ||
| Q1 24 | $2.0B | $671.5M |
| Q4 25 | $5.4B | $2.0B | ||
| Q3 25 | $5.3B | $1.8B | ||
| Q2 25 | $5.2B | $1.6B | ||
| Q1 25 | $4.9B | $1.9B | ||
| Q4 24 | $5.1B | $2.1B | ||
| Q3 24 | $4.9B | $2.1B | ||
| Q2 24 | $4.9B | $1.9B | ||
| Q1 24 | $4.7B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $49.0M | $192.7M |
| Free Cash FlowOCF − Capex | $-13.6M | $188.1M |
| FCF MarginFCF / Revenue | -1.0% | 26.6% |
| Capex IntensityCapex / Revenue | 4.5% | 0.6% |
| Cash ConversionOCF / Net Profit | 0.68× | 1.43× |
| TTM Free Cash FlowTrailing 4 quarters | $191.4M | $681.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.0M | $192.7M | ||
| Q3 25 | $78.6M | $246.2M | ||
| Q2 25 | $157.5M | $148.5M | ||
| Q1 25 | $140.2M | $125.8M | ||
| Q4 24 | $96.9M | $190.7M | ||
| Q3 24 | $91.3M | $149.1M | ||
| Q2 24 | $199.7M | $116.4M | ||
| Q1 24 | $234.7M | $152.7M |
| Q4 25 | $-13.6M | $188.1M | ||
| Q3 25 | $21.8M | $235.5M | ||
| Q2 25 | $106.6M | $142.4M | ||
| Q1 25 | $76.4M | $115.8M | ||
| Q4 24 | $34.4M | $183.0M | ||
| Q3 24 | $50.1M | $138.5M | ||
| Q2 24 | $167.4M | $103.5M | ||
| Q1 24 | $178.9M | $147.2M |
| Q4 25 | -1.0% | 26.6% | ||
| Q3 25 | 1.4% | 35.7% | ||
| Q2 25 | 7.9% | 23.6% | ||
| Q1 25 | 4.6% | 20.7% | ||
| Q4 24 | 2.6% | 34.1% | ||
| Q3 24 | 3.2% | 26.0% | ||
| Q2 24 | 12.3% | 19.6% | ||
| Q1 24 | 10.0% | 28.8% |
| Q4 25 | 4.5% | 0.6% | ||
| Q3 25 | 3.5% | 1.6% | ||
| Q2 25 | 3.8% | 1.0% | ||
| Q1 25 | 3.8% | 1.8% | ||
| Q4 24 | 4.6% | 1.4% | ||
| Q3 24 | 2.7% | 2.0% | ||
| Q2 24 | 2.4% | 2.4% | ||
| Q1 24 | 3.1% | 1.1% |
| Q4 25 | 0.68× | 1.43× | ||
| Q3 25 | 0.63× | 2.22× | ||
| Q2 25 | 3.42× | 1.65× | ||
| Q1 25 | 1.05× | 1.10× | ||
| Q4 24 | 1.47× | 1.63× | ||
| Q3 24 | 0.64× | 1.55× | ||
| Q2 24 | 2.61× | 1.32× | ||
| Q1 24 | 1.40× | 1.49× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASO
| Outdoors | $445.1M | 32% |
| Apparel | $349.8M | 25% |
| Footwear | $292.4M | 21% |
| Sports And Recreation | $288.7M | 21% |
| Other | $7.6M | 1% |
MEDP
| Metabolic | $249.8M | 35% |
| Oncology | $195.9M | 28% |
| Other | $88.3M | 12% |
| Central Nervous System | $73.2M | 10% |
| Cardiology | $63.0M | 9% |
| Antiviral And Anti Infective | $38.3M | 5% |
| Related Party | $10.3M | 1% |
